Real-Time CAD for Colonic Neoplasia: A RCT (CAD)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05963724 |
Recruitment Status :
Completed
First Posted : July 27, 2023
Last Update Posted : July 27, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Colorectal Cancer Colorectal Neoplasms | Device: Real-Time Computer Aided Detection Procedure: Stanford Colonoscopy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 1100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Screening |
Official Title: | Efficacy of Real-Time Computer Aided-Detected of Colonic Neoplasia in an Underserved Population, A Randomized Controlled Trial |
Actual Study Start Date : | September 1, 2022 |
Actual Primary Completion Date : | March 31, 2023 |
Actual Study Completion Date : | May 27, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: Real-Time Computer Aided Detection |
Device: Real-Time Computer Aided Detection
This intervention involves using computer-aided detection using a real-time system (GI-Genius, Medtronic) |
Active Comparator: Standard Colonoscopy |
Procedure: Stanford Colonoscopy
This involves white-light colonoscopy |
- Adenoma Detection Rate [ Time Frame: 1 year ]
- Adenomas Per Colon [ Time Frame: 1 year ]
- Sessile Serrated Lesion Detection Rate [ Time Frame: 1 year ]
- Sessile Serrated Lesions Per Colon [ Time Frame: 1 year ]
- False Neoplasia Rate [ Time Frame: 1 year ]
- Withdrawal Time [ Time Frame: 1 year ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years to 100 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Undergoing colonoscopy at RUHS
- Age > 45 years
- No contraindications to colonoscopy
Exclusion Criteria:
- Prior history of subtotal colectomy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05963724
United States, California | |
Riverside University Health System | |
Moreno Valley, California, United States, 92555 |
Responsible Party: | Riverside University Health System Medical Center |
ClinicalTrials.gov Identifier: | NCT05963724 |
Other Study ID Numbers: |
1922564-2 |
First Posted: | July 27, 2023 Key Record Dates |
Last Update Posted: | July 27, 2023 |
Last Verified: | July 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
artificial intelligence |
Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |